This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
For pharmasalesreps, these programs are not just tools for market penetration – they’re lifelines that improve healthcare accessibility across the country. For example, a major insulin manufacturer might partner with hospitals to offer subsidized insulin for low-income patients. What Are Drug Access Programs?
Two of ZS’ major studies suggest that the trend towards more advanced KAM strategies and capabilities will continue to accelerate for pharmamanufacturers. Furthermore, these studies demonstrate how KAM must be treated not simply as a role or as a sales or market access initiative, but as an organization-wide business strategy.
As mentioned, an understanding of a drugs pharmacodynamics and pharmacokinetics, as well as its mechanism of action, is significant in the eyes of an HCP as it helps providers draw a connection from the product to their patient population so salesreps can better understand their clients needs. PharmaSales.
In the fast-paced world of pharmasales in Malaysia, opportunities can come when you least expect them. For pharmasalesreps, this is a chance to introduce your product as an alternative, often with little resistance from healthcare providers. One such golden moment? When your competitors face stock shortages.
After a developmental day of shadowing a pharmasalesrep, the fire was lite and she joined the sales team never looking back, ultimately landing her a role at ConnectiveRx in 2010. Interestingly, her approach was not only shaped by professional aptitude.
With current trends suggesting that healthcare practitioners (HCPs) will continue to cut back on the amount of time devoted to one-on-one meetings with salesreps, every nuance of each interaction carries significant weight. Unlike human-administered role-play certification exams, AI can avoid bringing subjectivity into the scoring.
On one hand, it opens the door for generic manufacturers to step in, offering more affordable options to patients. On the other hand, original manufacturers often face tough competition, as the market becomes flooded with alternatives. For pharmasalesreps, this shift changes the conversation.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content